Revenue Update on RiceBran Technologies(NASDAQ:RIBT)

RiceBran Technologies(NASDAQ:RIBT) announced the earnings results for Fiscal Year 2016 and Q4. The results came in during After-Market on Mar 23, 2017. Based on the corporate Earnings and Guidance, many Investment Banking firms balance their portfolio to Sell and Buy Stocks based on their strategy of investing in stocks.Earnings per share were $-0.11.

RiceBran Technologies (RIBT) shares turned negative on Fridays trading session with the shares closing down -0.0069 points or -0.84% at a volume of 31,980. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $0.82. The peak price level was also seen at $0.82 while the days lowest was $0.78. Finally the shares closed at $0.81. The 52-week high of the shares is $2.1899 while the 52-week low is $0.735. According to the latest information available, the market cap of the company is $8.8 M.

Several Insider Transactions has been reported to the SEC. On May 23, 2016, W. John Short (CEO) purchased 10,000 shares at $1.48 per share price.Also, On Sep 8, 2015, David Goldman (director) purchased 4,000 shares at $2.46 per share price.

RiceBran Technologies is a human food ingredient functional food ingredient packaged functional food and animal nutrition company. The Company is focused on processing and marketing of healthy natural and nutrient dense products derived from raw rice an underutilized by-product of the rice milling industry. The Company has two operating segments: USA and Brazil. The Company’s USA segment manufactures and distributes stabilized rice bran (SRB) (for human food ingredient and animal nutrition customers) and derivative products. The Company’s Brazil segment extracts crude rice bran oil (RBO) and defatted rice bran (DRB) from rice bran which are then further processed into fully refined rice bran oil for sale internationally and in Brazil compounded animal nutrition products for horses cows swine sheep and poultry and a number of human food and animal nutrition products derivatives and co-products.

Add Comment